AgingResearch.NewsJoin free
Clinics and Practice

Myoprotective Fat-Loss Phenotypes in Obesity-Associated Type 2 Diabetes: A 12-Month Real-World Cohort Study of Metformin-Based Treatment Regimens

By Ioana Bujdei-Tebeică, Anca Pantea Stoian, Doina Andrada Mihai, Simona Diana Ștefan, Cristian Serafinceanu
Figure 1. Myoprotective fat-loss phenotype rate by treatment group.
Open the figure at full size
Figure 1. Myoprotective fat-loss phenotype rate by treatment group.Myoprotective fat-loss phenotype rate by treatment group.Bujdei-Tebeică et al.
Cohort study of 166 peopleInterventions

12 months, declared no competing interests

Paper

The paper

Ioana Bujdei-Tebeică, Anca Pantea Stoian, Doina Andrada Mihai, Simona Diana Ștefan, Cristian Serafinceanu

Carol Davila University of Medicine and Pharmacy

Clinics and Practice, 28 Jul 2026

doi.org/10.3390/clinpract16080141PubMed 42645137

More on Obesity